Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of €148.24 billion as of February 2, 2026. Its market cap has increased by 32.48% in one year.

Market Cap

148.24B

Enterprise Value

160.32B

Revenue

24.79B

Ranking

n/a

PE Ratio

21.45

Stock Price

€120.84

Market Cap Chart

Since January 22, 1992, Gilead Sciences's market cap has increased from 194.48M to 148.24B, an increase of 76,121.95%. That is a compound annual growth rate of 21.52%.

Market Cap History

Date	Market Cap	% Change
Jan 30, 2026	148.24B	14.29%
Dec 31, 2025	129.70B	16.64%
Dec 31, 2024	111.19B	21.76%
Dec 29, 2023	91.32B	-9.36%
Dec 30, 2022	100.75B	25.80%
Dec 31, 2021	80.09B	34.14%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Merck KGaA	54.59B
Siemens Healthineers AG	47.05B
Bayer Aktiengesellschaft	43.78B
Fresenius SE & Co. KGaA	26.59B
Sartorius Aktiengesellschaft	14.69B
Fresenius Medical Care AG	10.52B
Fielmann Group AG	3.48B
Carl Zeiss Meditec AG	2.45B

Market Cap Rankings